David James BSc (Hons) MREC CertRP’s Post

It's an exciting time for Novo Nordisk 🤩, as they've just announced they are partnering with Flagship Pioneering's Valo Health to develop a new AI-driven drug for cardiovascular diseases 💙. This collaboration brings together the expertise of two leading healthcare companies, with Novo Nordisk's 100 years of experience in diabetes and cardiovascular diseases, and Valo Health's innovative AI-driven approach to drug design and development. The new drug is expected to be the first of its kind, using artificial intelligence and machine learning to identify, design, and develop cardiovascular drugs. By using this AI-driven approach, Novo Nordisk and Valo Health are hoping to create the most effective drug possible, with the goal of having it to market as quickly as possible. 💪 We are looking forward to seeing the results of this collaboration, and how it will shape the future of cardiovascular research and development. 🔮 #NovoNordisk #ValoHealth #AIDrugs